Ghaziabad, India

Soumendu Paul

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soumendu Paul. Retrieved from https://idiyas.com/inventor/soumendu-paul-h7jhs6nh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Soumendu Paul: Innovator in Pharmaceutical Formulations

Introduction

Soumendu Paul is a notable inventor based in Ghaziabad, India. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work involving paclitaxel and its derivatives.

Latest Patents

Soumendu Paul holds a patent for "Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof." This invention focuses on the development of pharmaceutical formulations that utilize nanoparticles of co-polymeric micelles to enhance the delivery and efficacy of paclitaxel, a widely used chemotherapeutic agent.

Career Highlights

Throughout his career, Soumendu Paul has demonstrated a strong commitment to advancing pharmaceutical science. His work has the potential to improve treatment options for patients requiring chemotherapy, showcasing his dedication to innovation in healthcare.

Collaborations

Soumendu has collaborated with notable professionals in his field, including Amarnath Maitra and Sanjeeb Kumar Sahoo. These partnerships have contributed to the development and refinement of his innovative formulations.

Conclusion

Soumendu Paul's contributions to pharmaceutical formulations highlight his role as a key innovator in the industry. His work not only advances scientific knowledge but also has the potential to significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…